Inogen (INGN) Total Non-Current Liabilities (2013 - 2026)
Inogen (INGN) posted quarterly Total Non-Current Liabilities of $84.6 million for Q1 2026, down 10.19% year-over-year from $94.2 million in Q1 2025, and down 4.05% quarter-over-quarter from $88.2 million in Q4 2025.
Inogen (INGN) Total Non-Current Liabilities (2013 - 2026) Analysis & Trends
Inogen (INGN) has reported Total Non-Current Liabilities for 14 consecutive years, with $84.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Total Non-Current Liabilities fell 10.19% year-over-year to $84.6 million; the TTM figure through Mar 2026 stood at $84.6 million (down 10.19% YoY), while the FY2025 annual figure was $88.2 million, down 19.32% from the prior year.
- Total Non-Current Liabilities slipped to $84.6 million in Q1 2026 per INGN's latest filing, from $88.2 million in the prior quarter.
- Across five years, Total Non-Current Liabilities topped out at $113.1 million in Q1 2024 and bottomed at $84.6 million in Q1 2026.
- Historically, Total Non-Current Liabilities has averaged $100.7 million across 5 years, with a median of $104.6 million in 2024.
- Annual changes were most pronounced in 2024 — Total Non-Current Liabilities climbed 26.64% — and 2025, when it fell 19.32%.
- Inogen's Total Non-Current Liabilities stood at $95.5 million in 2022, then grew by 12.58% to $107.5 million in 2023, then increased by 1.67% to $109.3 million in 2024, then dropped by 19.32% to $88.2 million in 2025, then retreated by 4.05% to $84.6 million in 2026.
- Business Quant data shows INGN's Total Non-Current Liabilities at $84.6 million in Q1 2026, $88.2 million in Q4 2025, and $92.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 21.28 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 40.90 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 42.74 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 2.57 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 3.68 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 23.89 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 9.07 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 3.44 Bn |
| 10 | Inogen | 151.72 Mn | 46.18 Mn | 43.27 Mn | 92.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 92.75 Mn |
| Mar 31, 2026 | 84.63 Mn |
| Dec 31, 2025 | 88.20 Mn |
| Sep 30, 2025 | 92.02 Mn |
| Jun 30, 2025 | 95.56 Mn |
| Mar 31, 2025 | 94.23 Mn |
| Dec 31, 2024 | 109.33 Mn |
| Sep 30, 2024 | 104.59 Mn |
| Jun 30, 2024 | 110.14 Mn |
| Mar 31, 2024 | 113.13 Mn |
| Dec 31, 2023 | 107.53 Mn |
| Sep 30, 2023 | 109.89 Mn |
| Jun 30, 2023 | 86.98 Mn |
| Mar 31, 2023 | 92.36 Mn |
| Dec 31, 2022 | 95.51 Mn |
| Sep 30, 2022 | 111.11 Mn |
| Jun 30, 2022 | 106.39 Mn |
| Mar 31, 2022 | 109.76 Mn |
| Dec 31, 2021 | 112.04 Mn |
| Sep 30, 2021 | 113.33 Mn |